Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Pittsburgh
About this trial
A new mental health application will be developed for persons with schizophrenia and schizoaffective disorder. The aim is to look at whether it is feasible to use a mobile health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder and whether it is acceptable to that population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Persons diagnosed with schizophrenia and schizoaffective disorder and are in remission for past two months.
Age 18-60 years of any gender.
Able to read and understand Malayalam/ English
Disqualifiers
Patients who have active psychotic or mood symptoms.
History of substance use (except nicotine)
Having any serious physical illness. -
Trial design
Design model
Single group
Treatments tested in this trial
Intervention via mobile application
BehavioralIntervention via mobile application include psychoeducational videos, reminders, and virtual rewards and badges for completing the challenges to encourage adherence of medications
Treatment groups
44 Participants
are divided into 1 treatment groupGroup A: Intervention via mobile appExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Feasibility of Mobile app
To assess the feasibility and the acceptability with a mobile mental health application for medication adherence in persons with SZ and schizoaffective disorder using Acceptability Questionnaire. The scale ranges from 0 to 50.
Time frame
Baseline and after three months2
Acceptibility of Mobile app
To assess the feasibility and the acceptability with a mobile mental health application for medication adherence in persons with SZ and schizoaffective disorder using Perception of treatment Acceptability scale (Score (0-5) 0= Not at all 5 =very much). Ranges from 0 to 50. )
Time frame
Baseline and after three months3
Adherence to medication
To compare the Medication adherence rating scale scores before and after using mental health application for changing medication adherence in persons with schizophrenia and schizoaffective disorder
Time frame
Baseline and after three monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Pittsburgh
Lead sponsor
Fogarty International Center of the National Institute of Health
Collaborator
Government Medical College, Palakkad-678013
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: